Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
BRIEF COMMUNICATIONS

A Novel DNA Enzyme Reduces Glycosaminoglycan Chains in the Glial Scar and Allows Microtransplanted Dorsal Root Ganglia Axons to Regenerate beyond Lesions in the Spinal Cord

Barbara Grimpe and Jerry Silver
Journal of Neuroscience 11 February 2004, 24 (6) 1393-1397; https://doi.org/10.1523/JNEUROSCI.4986-03.2004
Barbara Grimpe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerry Silver
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  •   Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    The histogram shows the numbers of microtransplanted DRG axon fragments proximal and distal to the lesion in DNA enzyme-treated and untreated spinal cords.

  •   Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Confocal photomicrographs of TGF-β-stimulated primary astrocyte cultures treated with the DNA enzyme (A) or control DNA enzyme (B) or left untreated (C) and stained with the CS-56 antibody. Uptake of the biotin-streptavidin-labeled DNA enzyme can be seen in the astrocytes (D). Scale bars, 10 μm. E, F, RT-PCR-Southern blot of primary astrocyte cultures for XT-1 (E) and RT-PCR for GAPDH and cyclophilin (F) of the same mRNA. G, Dot blot of primary astrocyte cultures treated with the DNA enzyme or control DNA enzyme and stained with the CS-56 antibody. H, Restaining of the same dot blot with GFAP. I, RT-PCR-Southern blot for the XT-1 in a DNA enzyme- and control DNA enzyme-treated spinal cord.

  •   Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Confocal photomicrographs of treated and untreated spinal cords. Red/green (A) and green (A′) channels show the green DRGs and their axons passing the distinct borders of the lesion cores (red CS-56 staining) in a DNA enzyme-treated spinal cord. Axons that enter the lesion core become dystrophic (A, A′, arrows). Red/green (B) and green (B′) channels show an untreated spinal cord with the green DRG and red CS-56 staining. Note the struggling axon in the heart of the lesion. Scale bar, 50 μm. C, Diffusion of a labeled DNA enzyme in vivo 7 d after treatment. Scale bar, 100 μm. D, GFAP-stained section of the lesion area in a different animal. Note the disrupted astrocyte alignment in the core and borders of the lesion (L) and the aligned astrocytes (arrows) in the region where axons regenerate.

Tables

  • Figures
    • View popup
    Table 1.

    PCR conditions for XT-1, GAPDH, and cyclophilin

    Name Sequence Length of end product Reference
    XT-1 XT1s1 316bp Goetting et al. (2000)
    5′-CTTCATCCGCCTGGGTCTTCG-3′
    XT1as1
    5′-GTAGTGTGTGAATTCCGCAGTGG-3′
    nested XT1s2
    5′-GGGCTGAGTCATCGCTACACACG-3′
    nested XT1as2
    5′-CGATGACATTGACAGGATCCACC-3′
    GAPDH GAPDHs 78bp Tajima et al. (1999)
    5′-GAACATCATCCCTGCATACA-3′
    GAPDHas
    5′-CCAGTGAGCTTCCCGTTCA-3′
    Cyclophilin cyclo as 65 bp Danielson et al. (1988)
    5′-TGTGCCAGGGTGGTGACTT-3′
    cyclo as
    5′-TTTCTCTCCGTAGATGGACTT-3′
Back to top

In this issue

The Journal of Neuroscience: 24 (6)
Journal of Neuroscience
Vol. 24, Issue 6
11 Feb 2004
  • Table of Contents
  • About the Cover
  • Index by author
  • abstractBrowser.pdf
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Novel DNA Enzyme Reduces Glycosaminoglycan Chains in the Glial Scar and Allows Microtransplanted Dorsal Root Ganglia Axons to Regenerate beyond Lesions in the Spinal Cord
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
A Novel DNA Enzyme Reduces Glycosaminoglycan Chains in the Glial Scar and Allows Microtransplanted Dorsal Root Ganglia Axons to Regenerate beyond Lesions in the Spinal Cord
Barbara Grimpe, Jerry Silver
Journal of Neuroscience 11 February 2004, 24 (6) 1393-1397; DOI: 10.1523/JNEUROSCI.4986-03.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
A Novel DNA Enzyme Reduces Glycosaminoglycan Chains in the Glial Scar and Allows Microtransplanted Dorsal Root Ganglia Axons to Regenerate beyond Lesions in the Spinal Cord
Barbara Grimpe, Jerry Silver
Journal of Neuroscience 11 February 2004, 24 (6) 1393-1397; DOI: 10.1523/JNEUROSCI.4986-03.2004
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Heteromodal Cortical Areas Encode Sensory-Motor Features of Word Meaning
  • Pharmacologically Counteracting a Phenotypic Difference in Cerebellar GABAA Receptor Response to Alcohol Prevents Excessive Alcohol Consumption in a High Alcohol-Consuming Rodent Genotype
  • Neuromuscular NMDA Receptors Modulate Developmental Synapse Elimination
Show more Brief Communications
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.